COMT (catechol-O-methyltransferase) degrades catecholamines like adrenaline and dopamine, which modulate stress responses and glucose metabolism. Certain SNPs (e.g., rs4680, Val158Met) alter enzyme activity: the Met/Met genotype is linked to slower degradation, potentially higher baseline catecholamines, and modestly elevated fasting glucose or insulin resistance in some studies. However, the evidence is mixed and effect sizes are small. Most data come from candidate gene or GWAS studies with limited replication. There is no strong causal evidence that COMT directly regulates blood sugar; rather, it may influence stress-related glucose fluctuations. Consumer DNA tests that claim to predict blood sugar regulation via COMT are overstating the science. Lifestyle factors (diet, exercise, sleep) dominate glycemic control. Therefore, the relationship is plausible but not clinically actionable. Evidence grade: mechanistic/unclear.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-4e72cf0bd33a53a8c15632dc